Urinary Tract Infections (UTI) are the most common bacterial infection among Long Term Care residents and is the second most common infection diagnosed in the acute hospital setting, accounting for almost 5% of all emergency department visits by adults aged 65 years and older in the United States each year. Current culture methods are limited by their sensitivity, as well as ability to identify polymicrobial infection.

Empirical treatment of a UTI occurs in many patient populations, however, this practice has contributed to the antibiotic resistance trend occurring globally. Patients are treated with a course of antibiotics that may not be the optimal choice based on pathogens present.

The Promus Diagnostics proprietary molecular UTI assay includes 24 pathogens (gram positive, gram negative and fungi), coupled with three key antibiotic resistance markers in the same test and from the same sample. Our comprehensive test provides clinicians with a reliable and clear picture of the causative pathogens in asymptomatic patients.

Identification where culture or dipstick may not have detected infection, or inconclusive due to sample contamination.

Reduce or eliminate recurrent infections based on superior identification of uropathogens for proper treatment.

Informed drug selection to remediate infection, decrease incidents of adverse events as well as lessen the potential for antibiotic resistance.


Bladder Cancer:

  • Hematuria
  • Urine Cytology
  • Feulgen Stain
  • ProEx C

Urinary Tract Infection (UTI):

  • Acinetobacter baumannii
  • Actinobaculum schaalii
  • Aerococcus urinae
  • Candida spp.  (C. albicans, glabrata, Parapsilosis, tropicalis)
  • Citrobacter spp. (C. braakii, Freundii, koseri)
  • Enterobacter spp. (E. aerogenes, cloacae)
  • Enterococcus spp. (E. faecalis, faecium)
  • Escherichia coli (E. coli)
  • Haemophilus (H. influenzae, ducreyl)
  • Klebsiella  (K. oxytoca, pneumonia)
  • Morganella morganii
  • Mycobacterium tuberculosis
  • Proteus spp. (P. mirabilis, vulgaris)
  • Pseudomonas aeruginosa
  • Serratia marcescens
  • Staphylococcus aureus
  • Streptococcus agalactiae
  • Staphylococcus coagulase-neg. (S. saprophyticus, haemolyticus, epidermidis)
  • Streptococcus spp. (S. agalactiae, pneumonia, pyogenes)
  • Ureaplasma urealyticum

Sexually Transmitted Disease (STD):

  • Chlamydia trachomatis
  • Haemophilus ducreyi (Chancre)
  • HSV 2 (Genital Herpes)
  • Mycoplasma genitalium
  • Mycoplasma hominis
  • Neisseria gonorrhoeae
  • Treponema pallidum (Syphilis)
  • Trichomonas vaginalis
  • Ureaplasma urealyticum

Antibiotic Resistance Gene Class (ABR):

  • Beta-lactamase – Class A type
  • Beta-lactamase – Class C type (AmpC)
  • Beta-Lactamase – Class D type (Carbapenemase / Oxacillinase)
  • Beta-Lactamase – KPC type (Carbapenemase)
  • Extended Spectrum Beta-lactamase (ESBL)
  • Macrolides [Mycins]
  • Methicillin (mecA)
  • Fluoroquinolones
  • Tetracyclines
  • Trimethoprim-Sulfamethoxazole
  • Vancomycin